UPLC-MS/MS Technology for the Quantitative Methodology and Pharmacokinetic Analysis of Voxtalisib in Rat Plasma

Voxtalisib, is a specific, effective, and reversible dual inhibitor, which inhibits both pan-class I phosphoinositide 3-kinase (PI3K) and mechanistic target of rapamycin (mTOR). To date, voxtalisib has been studied in trials for melanoma, lymphoma, glioblastoma, breast cancer, and other cancers. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qingqing, Liu, Ya-nan, Wang, Jing, Hu, Yingying, Hu, Jinyu, Xu, Ren-ai, Shao, Liu, Chen, Lianguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237521/
https://www.ncbi.nlm.nih.gov/pubmed/35774599
http://dx.doi.org/10.3389/fphar.2022.914733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237521/
https://www.ncbi.nlm.nih.gov/pubmed/35774599
http://dx.doi.org/10.3389/fphar.2022.914733

Ejemplares similares